You just read:

Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis

News provided by

Bridge Biotherapeutics, Inc.

May 19, 2019, 20:38 ET